BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7768144)

  • 1. [Current progress in the treatment of acute promyelocytic leukemia with retinoic acid].
    Zeng H; Zhao XY
    Zhonghua Nei Ke Za Zhi; 1994 Dec; 33(12):848-50. PubMed ID: 7768144
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of acute leukemia by differentiation: effects of all trans retinoic acid in acute promyelocytic leukemia].
    Degos L
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):193-5. PubMed ID: 8337123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment of acute promyelocytic leukemia with retinoic acid].
    Iavorkovskiĭ LI; Udris OIu; Iavorkovskiĭ LL
    Ter Arkh; 1994; 66(2):87-9. PubMed ID: 8160157
    [No Abstract]   [Full Text] [Related]  

  • 4. All trans retinoic acid in acute promyelocytic leukemia.
    Degos L; Castaigne S; Fenaux P; Daniel MT; Dombret H; Chomienne C
    Nouv Rev Fr Hematol (1978); 1991; 33(2):183-5. PubMed ID: 1766850
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute promyelocytic leukemia: retinoic acid response and resistance.
    Early E; Dmitrovsky E
    J Investig Med; 1995 Aug; 43(4):337-44. PubMed ID: 7552583
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
    Cornic M; Delva L; Castaigne S; Lefebvre P; Balitrand N; Degos L; Chomienne C
    Leukemia; 1994; 8 Suppl 2():S16-9. PubMed ID: 7815831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trans-retinoic acid. Treatment by differentiation of acute promyelocytic leukemia].
    Castaigne S
    Soins; 1990; (538-539):24-6. PubMed ID: 2237532
    [No Abstract]   [Full Text] [Related]  

  • 8. All trans retinoic acid treatment for patients with acute promyelocytic leukemia.
    Fenaux P; Castaigne S; Chomienne C; Dombret H; Degos L
    Leukemia; 1992; 6 Suppl 1():64-6. PubMed ID: 1548938
    [No Abstract]   [Full Text] [Related]  

  • 9. Retinoic acid and steroid in acute promyelocytic leukemia.
    Hiçsönmez G
    Leukemia; 2003 Jun; 17(6):1203. PubMed ID: 12764396
    [No Abstract]   [Full Text] [Related]  

  • 10. Retinoic acids in the treatment of acute promyelocytic leukemia.
    Castaigne S; Chomienne C; Daniel MT; Berger R; Miclea JM; Ballerini P; Degos L
    Nouv Rev Fr Hematol (1978); 1990; 32(1):36-8. PubMed ID: 2190178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [All-trans-retinoic acid in the treatment of promyelocytic leukemia].
    Nousiainen T; Jantunen E
    Duodecim; 1993; 109(16):1410-4. PubMed ID: 7720600
    [No Abstract]   [Full Text] [Related]  

  • 12. Retinoic acid and arsenic for treating acute promyelocytic leukemia.
    Zhou GB; Zhao WL; Wang ZY; Chen SJ; Chen Z
    PLoS Med; 2005 Jan; 2(1):e12. PubMed ID: 15696202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.
    Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P
    Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.
    Huang ME; Ye YC; Chen SR; Chai JR; Lu JX; Zhao L; Gu LJ; Wang ZY
    Haematol Blood Transfus; 1989; 32():88-96. PubMed ID: 2696695
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathogenesis and management of acute promyelocytic leukemia.
    Warrell RP
    Annu Rev Med; 1996; 47():555-65. PubMed ID: 8712802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid and its rearranged receptor in the etiology and treatment of acute promyelocytic leukemia.
    Frankel SR; Miller WH; Dmitrovsky E
    Oncology (Williston Park); 1992 Aug; 6(8):74-78, 83; discussion 84, 87-8. PubMed ID: 1323988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recently recognized entity associated with the treatment of acute promyelocytic leukemia: the retinoic acid syndrome.
    Marinakis T; Papadimitriou CA; Koufos C; Fertakis A
    Haematologica; 1993; 78(3):192-4. PubMed ID: 8375752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin.
    Breccia M; Latagliata R; Carmosino I; Cannella L; Diverio D; Guarini A; De Propris MS; Petti MC; Avvisati G; Cimino G; Mandelli F; Lo-Coco F
    Haematologica; 2008 Dec; 93(12):1918-20. PubMed ID: 18945746
    [No Abstract]   [Full Text] [Related]  

  • 19. All-trans retinoic acid in acute promyelocytic leukemia in late pregnancy.
    Stentoft J; Nielsen JL; Hvidman LE
    Leukemia; 1994; 8 Suppl 2():S77-80. PubMed ID: 7815844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and overcoming of ATRA resistance in acute promyelocytic leukemia.
    Lo Coco F
    Haematologica; 1999 Nov; 84(11):961-2. PubMed ID: 10553153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.